+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of a systematic theory of suspension inhalation aerosols ii. aggregates of monodisperse particles nebulized in polydisperse droplets

Development of a systematic theory of suspension inhalation aerosols ii. aggregates of monodisperse particles nebulized in polydisperse droplets

International Journal of Pharmaceutics (Kidlington) 41(1-2): 147-158

Using the previously developed statistical framework to study the aggregation of primary drug particles in droplets formed on nebulization of supensions, we have computed the expected size distributions of clusters of monodisperse primary drug particles obtained after drying of log-normally distributed polydisperse aerosol droplet sprays. In systems with a high ratio of droplet to primary particle diameters and relatively high average number of particles per droplet, the cluster size distributions were found to be essentially log-normal with the same geometric standard deviations as the droplets, and the mass median (aerodynamic) diameters were accurately predictable on the basis of assumption of uniform distribution of the solid throughout the liquid phase. In systems where the average number of primary particles per droplet was less than one, the cluster size distributions showed markedly non-linear behaviour on log-normal probability graphs. However, the mass median (aerodynamic) diameters could still be predicted quite reliably assuming uniform distribution of the solid among the fraction of the droplets expected to be occupied by the solid particles (i.e. excluding the empty droplets from the calculations). When the ratio of the droplet to primary particles was small and the concentration of the suspension was high, the size distributions of the aggregates deviated markedly from the log-normal function, particularly when the droplet sprays were narrowly distributed. Calculation of the mass median (aerodynamic) diameters and geometric standard deviations using the uniform distribution assumption could lead to grossly erroneous results in these systems. The reason for this behaviour is that (i) spherical particles cannot fill space completely and (ii) a significant portion of the log-normally distributed droplets is too small to accommodate the number of primary particles which would be computed for these droplets on purely statistical grounds. This 'exclusion' effect, however, becomes marked only at high concentrations which are beyond the range used in current therapeutic aerosols and outside the regions of validity of some of the assumptions of the present theory. Thus, assuming uniform distribution of solid in the droplets of aerosol sprays, it is possible to estimate the significance of formation of solid aggregates arising for purely statistical reasons (i.e., without taking into account any forces of attraction causing flocculation or coagulation). Outside the regions of validity of the assumption of uniform distribution, the full computational model developed in this paper has to be used to find the median size and the shape of the distribution of the solid clusters.

Accession: 005132124

Download citation: RISBibTeXText

DOI: 10.1016/0378-5173(88)90147-0

Download PDF Full Text: Development of a systematic theory of suspension inhalation aerosols ii. aggregates of monodisperse particles nebulized in polydisperse droplets

Related references

Development of a systematic theory of suspension inhalation aerosols i. a framework to study the effects of aggregation on the aerodynamic behavior of drug particles. International Journal of Pharmaceutics (Kidlington) 27(1): 99-116, 1985

Simulation study of electric-guided delivery of 0.4µm monodisperse and polydisperse aerosols to the ostiomeatal complex. Computers in Biology and Medicine 72: 1-12, 2016

Regional deposition of inhaled 137 Cs-labeled monodisperse and polydisperse aluminosilicate aerosols in Syrian hamsters. American Industrial Hygiene Association Journal 39(12): 1009-1018, 1978

Retention of monodisperse or polydisperse aluminosilicate particles inhaled by dogs, rats, and mice. Toxicology and Applied Pharmacology 69(3): 345-362, 1983

Fractal Aggregates of Polydisperse Particles. Journal of Colloid and Interface Science 205(2): 459-469, 1998

Production of relatively monodisperse aerosols for inhalation experiments by aerosol centrifugation. Health Physics 21(4): 531-535, 1971

Decrease in specific airway conductance following inhalation of nebulized aerosols. Indian Journal of Chest Diseases 15(4): 272-275, 1973

Droplet size distributions of nebulized aerosols for inhalation therapy. Clinical Physics & Physiological Measurement 7(2): 139-146, 1986

Monodisperse red blood cell-like particles via consolidation of charged droplets. Journal of Colloid and Interface Science 361(2): 423-428, 2011

Technology for the production of monodisperse aerosols of oxides of transuranic elements for inhalation experiments. Health Physics 22(6): 837-843, 1972

Measurement of Fractal Aggregates of Polydisperse Particles Using Small-Angle Light Scattering. Journal of Colloid and Interface Science 221(2): 186-194, 2000

Total and regional lung retention of monodisperse cobalt compound aerosols after a single inhalation. Zeitschrift für Erkrankungen der Atmungsorgane 164(1): 61-66, 1985

Formation of monodisperse hierarchical lipid particles utilizing microfluidic droplets in a nonequilibrium state. Langmuir 31(8): 2334-2341, 2015

Microfluidic large-scale integration on a chip for mass production of monodisperse droplets and particles. Lab on A Chip 8(2): 287-293, 2008

Clinical use of nebulized budesonide inhalation suspension in a child with asthma. Journal of Allergy & Clinical Immunology 104(4 PART 2): S210-S214, 1999